Clinical Trials
2.9k
Active:477
Completed:1191
Trial Phases
6 Phases
Early Phase 1:75
Phase 1:720
Phase 2:1004
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2425 trials with phase data)β’ Click on a phase to view related trials
Phase 2
1004 (41.4%)Phase 1
720 (29.7%)Not Applicable
496 (20.5%)Phase 3
102 (4.2%)Early Phase 1
75 (3.1%)Phase 4
28 (1.2%)NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy
Not Applicable
Not yet recruiting
- Conditions
- PsilocybinNeuropathy
- Interventions
- Other: Standard of Care (SOC)
- First Posted Date
- 2025-11-13
- Last Posted Date
- 2025-11-13
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 83
- Registration Number
- NCT07227909
- Locations
- πΊπΈ
MD Anderson Cancer Center, Houston, Texas, United States
Nanosecond Pulsed Field Ablation in the Management of Benign Thyroid Nodules
Not yet recruiting
- Conditions
- Thyroid NodulesPulsed Field Ablation
- First Posted Date
- 2025-11-10
- Last Posted Date
- 2025-11-10
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT07226804
- Locations
- πΊπΈ
MD Anderson Cancer Center, Houston, Texas, United States
NBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung Cancer
Not Applicable
Not yet recruiting
- Conditions
- Locally-Advanced Non-Small Cell Lung Cancer
- Interventions
- First Posted Date
- 2025-11-04
- Last Posted Date
- 2025-11-04
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 40
- Registration Number
- NCT07224152
- Locations
- πΊπΈ
The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
Phase II Trial of Regorafenib Plus Lorigerlimab in Patients With Locally Recurrent or Regrowing pMMR/MSS Localized Rectal Cancer
Not Applicable
Not yet recruiting
- Conditions
- Rectal CancerRectal Cancer Recurrent
- Interventions
- First Posted Date
- 2025-11-03
- Last Posted Date
- 2025-11-03
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT07223567
- Locations
- πΊπΈ
The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
Registry Trial and Needs Assessment of Patients With Young-onset Lung Cancer: Impact of a Dedicated Care Program on Patient Experience and Outcomes
Recruiting
- Conditions
- Lung Cancer
- First Posted Date
- 2025-10-23
- Last Posted Date
- 2025-10-23
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 75
- Registration Number
- NCT07220096
- Locations
- πΊπΈ
The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 586
- Next
News
No news found